tiprankstipranks
Innate Pharma publishes IPH6501 data in Science Immunology
PremiumThe FlyInnate Pharma publishes IPH6501 data in Science Immunology
1M ago
Innate Pharma appoints Jonathan Dickinson as CEO
Premium
The Fly
Innate Pharma appoints Jonathan Dickinson as CEO
2M ago
Innate Pharma announces FDA clearance of IPH4502 IND
Premium
The Fly
Innate Pharma announces FDA clearance of IPH4502 IND
3M ago
Innate Pharma doses first patient in Sanofi-sponsored trial of SAR443579
PremiumThe FlyInnate Pharma doses first patient in Sanofi-sponsored trial of SAR443579
8M ago
Innate Pharma announces first patient dosed in IPH6501 trial
Premium
The Fly
Innate Pharma announces first patient dosed in IPH6501 trial
10M ago
Innate Pharma announces Yannis Morel broadens remit to COO
Premium
The Fly
Innate Pharma announces Yannis Morel broadens remit to COO
12M ago
Innate Pharma announces partial clinical hold on lacutamab IND placed by FDA
PremiumThe FlyInnate Pharma announces partial clinical hold on lacutamab IND placed by FDA
1y ago
Innate Pharma reports encore presentation of TELLOMAK Phase 2 study results
Premium
The Fly
Innate Pharma reports encore presentation of TELLOMAK Phase 2 study results
1y ago
Innate Pharma price target lowered to $8 from $12 at Citi
Premium
The Fly
Innate Pharma price target lowered to $8 from $12 at Citi
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100